Scarica l'app Stockscreener
200.29
0.85%
1.69
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RMD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Resmed Inc Borsa (RMD) Ultime notizie
AirSense 10 ClimateLineAir Heated Tube from ResMed Inc.quieter nights with smarter humidity - Ad-hoc-news.de
ResMed muted ahead of next earnings, shares trade steadily on NYSE - Ad-hoc-news.de
OLD National Bancorp IN Has $4.58 Million Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc. sees fresh institutional buying, shares hover near 200 dollars - Ad-hoc-news.de
ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh - TradingView
Price to earnings forward of ResMed Inc. – NYSE:RMD - TradingView
Price to earnings forward of ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh – MUN:RMEA - TradingView
Price to sales forward of ResMed Inc. – NYSE:RMD - TradingView
ResMed clears key trading range, shares hold firm between support and resistance - Ad-hoc-news.de
Should you continue to hold Resmed stock in your portfolio? - MSN
ResMed Inc. stock rises Thursday, outperforms market - MarketWatch
ResMed clears a fresh 52-week high, shares extend their Nasdaq run - Ad-hoc-news.de
Why ResMed Inc (RMD) Is Set to Outperform the Market: Insights i - GuruFocus
Price to book forward of ResMed Inc. – NYSE:RMD - TradingView
ResMed Stock is Down 20% in 2026. Is It a Buying Opportunity or a Warning Sign? - TIKR.com
ResMed Inc. Actuals & Estimates (NYSE:RMD) - TradingView
ResMed (ASX:RMD) Stock Moves Higher — What Investors Should Know? - Kalkine
Is ResMed Inc. (RMD) Stock Still a Long-Term Winner as OSA Market Expansion Continues? - Insider Monkey
Enterprise value to EBITDA forward of ResMed Inc. – NYSE:RMD - TradingView
ResMed opens the week with clear technical signals, shares trade in a defined range - Ad-hoc-news.de
Resmed Inc (RMD) Institutional Confidence - TradingKey
Did Morgan Stanley’s GLP-1 Downgrade Just Shift ResMed's (RMD) Investment Narrative? - Sahm
Resmed Inc (RMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Resmed Inc (RMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Should I buy CSL and ResMed shares right now? - The Motley Fool Australia
ResMed downgraded at Morgan Stanley on Philips re-entry and GLP-1 headwinds - MSN
ResMed edges higher after mixed analyst signals, shares trade near recent targets - AD HOC NEWS
Could ResMed (NYSE:RMD) Be Entering a New Chapter in Sleep Care? - Kalkine Media
ResMed trims KeyBanc price target, analyst views on the shares stay constructive - AD HOC NEWS
William Blair Maintains ResMed(RMD.US) With Buy Rating - Moomoo
KeyBanc Adjusts Price Target on ResMed to $266 From $290, Maintains Overweight Rating - marketscreener.com
ResMed Inc. (RMD) Stock Analysis: Unveiling A 39% Potential Upside Amidst Solid Growth - DirectorsTalk Interviews
Resmed Inc (RMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
KeyBanc Maintains ResMed(RMD.US) With Buy Rating, Announces Target Price $266 - Moomoo
Is ResMed (NYSE:RMD) Market Reset Creating New Interest? - Kalkine Media
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) was downgraded to a Hold Rating at Morgan Stanley - The Globe and Mail
Resmed Inc (RMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is ResMed stock underperforming the Dow? - MSN
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos - The Globe and Mail
Resmed Inc (RMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Resmed Inc (RMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ResMed Is Near Its 52-Week Low Despite 21% EPS Growth: What the GLP-1 Fear Is Getting Wrong - TIKR.com
ResMed Loses Bull as Margin Outlook Moderates -- Market Talk - Moomoo
Resmed Closes Acquisition of Noctrix Health - Moomoo
ResMed Inc (RMD) Stock Down 3.9% -- Now Undervalued? GF Score: 9 - GuruFocus
ResMed Inc. stock falls Wednesday, underperforms market - MarketWatch
Why ResMed (RMD) Shares Are Falling Today - Yahoo Finance
ResMed (RMD) Faces Downgrade Amid Market Concerns - GuruFocus
ResMed Shares Fall After Morgan Stanley Downgrade - Moomoo
Lobbying Update: $40,000 of RESMED CORP. lobbying was just disclosed - Quiver Quantitative
ResMed Inc. Stock 12‑Month Price Target Cut to $277.74, Implies 43% Upside - TradingView
This ResMed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
ResMed stock downgraded at Morgan Stanley (RMD:NYSE) - Seeking Alpha
Resmed Completes Acquisition of Noctrix Health - San Diego Business Journal
Morgan Stanley Downgrades ResMed(RMD.US) to Hold Rating, Cuts Target Price to $230 - Moomoo
Morgan Stanley downgrades ResMed stock rating on margin concerns - Investing.com
Morgan Stanley Downgrades ResMed to Equalweight From Overweight, Adjusts PT to $230 From $286 - marketscreener.com
Morgan Stanley downgrades ResMed stock rating on margin concerns By Investing.com - Investing.com UK
Analyst recommendations: Block, Resmed, Applied Materials, Ge Vernova, Intel… - marketscreener.com
ResMed Inc. stock falls Monday, underperforms market - MarketWatch
ResMed Is Maintained at Buy by Citigroup - Moomoo
Do experts rate BHP, Cochlear, and ResMed shares as buys, holds, or sells? - MSN
Citigroup Adjusts Price Target on ResMed to $270 From $340, Maintains Buy Rating - marketscreener.com
2.91%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):